Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Marcos-Pinto

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Biochimica Et Biophysica Acta|July 7, 2015
Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathwaysAna Magalhães, Ricardo Marcos-Pinto, Alison V Nairn, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2018
Metabolic control of T cell immune response through glycans in inflammatory bowel diseaseAna M Dias, Alexandra Correia, Márcia S Pereira, et al.
Endoscopy|September 3, 2025
Adherence to Clinical Practice Guidelines for Management of Epithelial Precancerous Conditions and Lesions in the Stomach in EuropeFilipa Fontes, Noa E A Kapteijn, Cesare Hassan, et al.
Cancer Immunology Research|September 16, 2020
Glycans as Immune Checkpoints: Removal of Branched N-glycans Enhances Immune Recognition Preventing Cancer ProgressionMariana C Silva, Ângela Fernandes, Maria Oliveira, et al.
Endoscopy|March 20, 2025
Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025Mário Dinis-Ribeiro, Diogo Libânio, Hugo Uchima, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 23, 2014
Health-related quality of life and utilities in gastric premalignant conditions and malignant lesions: a multicentre study in a high prevalence countryMiguel Areia, Susana Alves, Daniel Brito, et al.
Scandinavian Journal of Gastroenterology|June 30, 2025
External multicenter validation of the FAMISH score for predicting metachronous gastric lesions after endoscopic submucosal dissectionMónica Garrido, Tatiana Cruz Almeida, Ricardo Kuttner-Magalhães, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2021
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Ángeles Pérez Aísa, et al.
Gut|October 26, 2024
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for <i>Helicobacter pylori</i> infection between 2013 and 2021: results from the European registry on <i>H. pylori</i> management (Hp-EuReg)Llum Olmedo, Xavier Calvet, Emili Gené, et al.
Helicobacter|March 17, 2020
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)Olga P Nyssen, Ángeles Pérez-Aisa, Bojan Tepes, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Biochimica Et Biophysica Acta|July 7, 2015
Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathwaysAna Magalhães, Ricardo Marcos-Pinto, Alison V Nairn, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2018
Metabolic control of T cell immune response through glycans in inflammatory bowel diseaseAna M Dias, Alexandra Correia, Márcia S Pereira, et al.
Endoscopy|September 3, 2025
Adherence to Clinical Practice Guidelines for Management of Epithelial Precancerous Conditions and Lesions in the Stomach in EuropeFilipa Fontes, Noa E A Kapteijn, Cesare Hassan, et al.
Cancer Immunology Research|September 16, 2020
Glycans as Immune Checkpoints: Removal of Branched N-glycans Enhances Immune Recognition Preventing Cancer ProgressionMariana C Silva, Ângela Fernandes, Maria Oliveira, et al.
Endoscopy|March 20, 2025
Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025Mário Dinis-Ribeiro, Diogo Libânio, Hugo Uchima, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 23, 2014
Health-related quality of life and utilities in gastric premalignant conditions and malignant lesions: a multicentre study in a high prevalence countryMiguel Areia, Susana Alves, Daniel Brito, et al.
Scandinavian Journal of Gastroenterology|June 30, 2025
External multicenter validation of the FAMISH score for predicting metachronous gastric lesions after endoscopic submucosal dissectionMónica Garrido, Tatiana Cruz Almeida, Ricardo Kuttner-Magalhães, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2021
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Ángeles Pérez Aísa, et al.
Gut|October 26, 2024
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for <i>Helicobacter pylori</i> infection between 2013 and 2021: results from the European registry on <i>H. pylori</i> management (Hp-EuReg)Llum Olmedo, Xavier Calvet, Emili Gené, et al.
Helicobacter|March 17, 2020
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)Olga P Nyssen, Ángeles Pérez-Aisa, Bojan Tepes, et al.
Pageof 6